|
MGC57346 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49470436028309E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.43769498715119E-15 |
| Normal-vs-Stage2 |
3.67089999953052E-07 |
| Normal-vs-Stage3 |
2.71271893836911E-12 |
| Normal-vs-Stage4 |
1.65545355201857E-12 |
| Stage1-vs-Stage2 |
4.136600E-01 |
| Stage1-vs-Stage3 |
1.269380E-01 |
| Stage1-vs-Stage4 |
1.318070E-03 |
| Stage2-vs-Stage3 |
6.040400E-02 |
| Stage2-vs-Stage4 |
5.176200E-03 |
| Stage3-vs-Stage4 |
1.053780E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.14620000555033E-08 |
| Normal-vs-Asian |
2.80440115574265E-11 |
| Caucasian-vs-AfricanAmerican |
9.751400E-01 |
| Caucasian-vs-Asian |
3.214600E-01 |
| AfricanAmerican-vs-Asian |
4.893600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89848137210902E-14 |
| Normal-vs-Female |
2.71109801275315E-11 |
| Male-vs-Female |
3.475400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69086966650411E-12 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-15 |
| Normal-vs-Age(61-80Yrs) |
1.61499702500123E-11 |
| Normal-vs-Age(81-100Yrs) |
1.738040E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.230200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.116000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.546400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.036000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.438600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.983000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.82349999999976E-05 |
| Classical-VS-Follicular |
1.584990E-01 |
| Classical-VS-Other |
9.631800E-01 |
| Classical-VS-Normal |
6.72659705713841E-11 |
| Tall-VS-Follicular |
4.14120000000739E-05 |
| Tall-VS-Other |
2.831000E-01 |
| Tall-VS-Normal |
4.66293670342566E-15 |
| Follicular-VS-Other |
6.896600E-01 |
| Follicular-VS-Normal |
1.89009999984613E-07 |
| Other-VS-Normal |
6.003100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68919989107508E-10 |
| Normal-vs-N1 |
4.04898337080795E-13 |
| N0-vs-N1 |
7.402000E-03 |
|
|
